Guardant Health to Share Data Supporting Critical Role of Blood-Based Testing in Improving Cancer Screening Adherence at ACG 2025
Expanded cohort reiterates strong adherence rate of over 90% for Shield blood-based…
MNT Soars on Bybit: Record-Breaking 450% Volume Surge Marks Stellar Q3 Performance
Bybit x Mantle Roadmap Fuels Explosive Growth in Trading Activity and AUM…
Ban Ki-moon Visits Chery Group’s LEPAS Pavilion to Promote a Greener Mobility Future
WUHU, China, Oct. 22, 2025 /PRNewswire/ -- On October 20, during the…
Avacta presents first preclinical data from dual payload pre|CISION medicines at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets
First-in-class dual payload peptide drug conjugate delivers two complementary therapies from a…
CGTN AMERICA & CCTV UN: Global Dialogue on Innovation, Openness and Shared Development
WASHINGTON, Oct. 23, 2025 /PRNewswire/ -- CGTN America & CCTV UN releases…
Bybit Enhances Capital Mobility for VIP and Institutional Traders with Expanded Withdrawal Limits
DUBAI, UAE, Oct. 24, 2025 /PRNewswire/ --Â Bybit, the world's second-largest cryptocurrency exchange…
Shanghai Electric Signs Parau Phase II 342 MW PV Project with Econergy, Supporting Romania’s Green Future
As Shanghai Electric's fourth photovoltaic project in Romania, this initiative marks a…
ITM Announces Analyses from Phase 3 COMPETE Data Showing Higher Objective Response Rates with n.c.a. 177Lu-edotreotide (ITM-11) vs. Everolimus Across Subgroups of Patients with GEP-NETs at NANETS 2025 Annual Symposium
Austin, Texas, October 25, 2025 – ITM Isotope Technologies Munich SE (ITM),…
Aletheia Capital Endeavours Launches RepIntel, a Campaign-Grade Platform to Accelerate Global Access to Therapies
October 24, 2025 23:37 ET Â | Source: RepIntel. New York, New York,…
LEPAS Elegant Technology, Defined by You: LEPAS Fun Test Drive Interprets a New Paradigm for Intelligent Driving via User Co-Creation
WUHU, China, Oct. 24, 2025 /PRNewswire/ -- From October 18 to 19,…